Literature DB >> 11340247

Immunological evaluation of patients with beta-thalassemia major.

R Consolini1, A Calleri, A Legitimo, F Massei.   

Abstract

Abnormalities in the immune system and zinc homeostasis in patients with beta-thalassemia major (TM) have been reported. Since zinc ion is essential for the efficiency of the immune system and is required to induce biological activity to thymulin (Zn-FTS), a biochemically defined thymic hormone, we investigated the plasma levels of zinc and both active thymulin (Zn-FTS) and total zinc saturable thymulin (Zn-FTS+FTS) in 18 patients with TM aged between 2 and 31 years and 22 normal controls of the same age. Inhibitory molecules anti-thymulin and the distribution of lymphocyte subsets were also analyzed. Patients with TM presented significantly lowered plasma zinc and thymulin levels when compared to normal subjects. The significant enhancement of the active form of the hormone after zinc addition in vitro suggests that low thymulin values found in TM are due not to a thymic failure in synthesizing and secreting the thymic hormone, but a defect in zinc saturation of the hormone. An impairment of cell subset distribution was also demonstrated. This study shows that zinc and thymulin deficiency contribute to the complex mechanisms underlying immune dysfunction in TM. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11340247     DOI: 10.1159/000046526

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  4 in total

1.  Nutrition in Thalassemia: A Systematic Review of Deficiency, Relations to Morbidity, and Supplementation Recommendations.

Authors:  Elijah K Goldberg; Ashutosh Lal; Ellen B Fung
Journal:  J Pediatr Hematol Oncol       Date:  2022-01-01       Impact factor: 1.289

2.  Regulatory B-cell compartment in transfused alloimmunized and non-alloimmunized patients with sickle cell disease.

Authors:  Weili Bao; Hui Zhong; Deepa Manwani; Ljiljana Vasovic; Joan Uehlinger; Margaret T Lee; Sujit Sheth; Patricia Shi; Karina Yazdanbakhsh
Journal:  Am J Hematol       Date:  2013-06-20       Impact factor: 10.047

3.  Zinc supplementation improves bone density in patients with thalassemia: a double-blind, randomized, placebo-controlled trial.

Authors:  Ellen B Fung; Janet L Kwiatkowski; James N Huang; Ginny Gildengorin; Janet C King; Elliott P Vichinsky
Journal:  Am J Clin Nutr       Date:  2013-08-14       Impact factor: 7.045

4.  Comment on: oxidative stress and antioxidant status in beta-thalassemia heterozygotes.

Authors:  Hossain Uddin Shekhar
Journal:  Rev Bras Hematol Hemoter       Date:  2013
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.